Harvard Bioscience (FRA:HBI) Research & Development : €10.9 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Harvard Bioscience Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Harvard Bioscience's Research & Development for the three months ended in Dec. 2023 was €2.9 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was €10.9 Mil.

Harvard Bioscience Research & Development Historical Data

The historical data trend for Harvard Bioscience's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harvard Bioscience Research & Development Chart

Harvard Bioscience Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

9.64

7.14

9.56

11.64

10.79

Harvard Bioscience Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Research & Development	Get a 7-Day Free Trial															2.69	2.71	2.73	2.59	2.89

Harvard Bioscience Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €10.9 Mil.

Harvard Bioscience (FRA:HBI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Harvard Bioscience Research & Development Related Terms

Thank you for viewing the detailed overview of Harvard Bioscience's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Harvard Bioscience (FRA:HBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Harvard Bioscience Inc (FRA:HBI) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

HBIO:USA HBI:Germany

Address

84 October Hill Road, Holliston, MA, USA, 01746

Website

https://www.harvardbioscience.com

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.